title: A challenging case: how should an IRB rule when a protocol calls for using an extremely vulnerable population: the dying?
authors.affiliation: Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University, OH, USA.
authors.forename: George
authors.initials: G
authors.lastname: Agich
authors.forename: David
authors.initials: D
authors.lastname: Smith
authors.forename: Robert
authors.initials: R
authors.lastname: Levine
mesh_terms: D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D017321:Clinical Trials, Phase I as Topic / Q000941:ethics; D028744:Ethics Committees, Research; D006805:Human Experimentation / Q000941:ethics*; D006801:Humans; D007258:Informed Consent / Q000941:ethics; D035842:Research Subjects; D019452:Terminally Ill; D035862:Vulnerable Populations
chemical_list: D016915:AIDS Vaccines